ASAPF
Price
$0.19
Change
-$0.00 (-0.00%)
Updated
Dec 24 closing price
Capitalization
14.54M
Intraday BUY SELL Signals
EMITF
Price
$0.05
Change
-$1.60 (-96.97%)
Updated
Dec 2 closing price
Capitalization
16.36M
Intraday BUY SELL Signals
Interact to see
Advertisement

ASAPF vs EMITF

Header iconASAPF vs EMITF Comparison
Open Charts ASAPF vs EMITFBanner chart's image
Aurora Spine
Price$0.19
Change-$0.00 (-0.00%)
Volume$2.69K
Capitalization14.54M
Elbit Imaging
Price$0.05
Change-$1.60 (-96.97%)
Volume$4.33K
Capitalization16.36M
ASAPF vs EMITF Comparison Chart in %
ASAPF
Daily Signal:
Gain/Loss:
EMITF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ASAPF vs. EMITF commentary
Dec 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASAPF is a Hold and EMITF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 25, 2025
Stock price -- (ASAPF: $0.19 vs. EMITF: $0.05)
Brand notoriety: ASAPF and EMITF are both not notable
ASAPF represents the Medical/Nursing Services, while EMITF is part of the Financial Conglomerates industry
Current volume relative to the 65-day Moving Average: ASAPF: 7% vs. EMITF: 252%
Market capitalization -- ASAPF: $14.54M vs. EMITF: $16.36M
ASAPF [@Medical/Nursing Services] is valued at $14.54M. EMITF’s [@Financial Conglomerates] market capitalization is $16.36M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $217.03B to $0. The market cap for tickers in the [@Financial Conglomerates] industry ranges from $590.24B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.7B. The average market capitalization across the [@Financial Conglomerates] industry is $176.05M.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASAPF’s FA Score shows that 1 FA rating(s) are green whileEMITF’s FA Score has 1 green FA rating(s).

  • ASAPF’s FA Score: 1 green, 4 red.
  • EMITF’s FA Score: 1 green, 4 red.
According to our system of comparison, both ASAPF and EMITF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASAPF’s TA Score shows that 4 TA indicator(s) are bullish while EMITF’s TA Score has 2 bullish TA indicator(s).

  • ASAPF’s TA Score: 4 bullish, 5 bearish.
  • EMITF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, EMITF is a better buy in the short-term than ASAPF.

Price Growth

ASAPF (@Medical/Nursing Services) experienced а -7.41% price change this week, while EMITF (@Financial Conglomerates) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.01%. For the same industry, the average monthly price growth was +1.99%, and the average quarterly price growth was +13.68%.

The average weekly price growth across all stocks in the @Financial Conglomerates industry was +3.46%. For the same industry, the average monthly price growth was +3.66%, and the average quarterly price growth was +62.07%.

Industries' Descriptions

@Medical/Nursing Services (+1.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Financial Conglomerates (+3.46% weekly)

Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EMITF($16.4M) has a higher market cap than ASAPF($14.5M). ASAPF YTD gains are higher at: -32.796 vs. EMITF (-96.600). ASAPF has higher annual earnings (EBITDA): -121.65K vs. EMITF (-3.62M). EMITF has more cash in the bank: 149M vs. ASAPF (666K). ASAPF has less debt than EMITF: ASAPF (3.59M) vs EMITF (258M). EMITF has higher revenues than ASAPF: EMITF (23.5M) vs ASAPF (18M).
ASAPFEMITFASAPF / EMITF
Capitalization14.5M16.4M88%
EBITDA-121.65K-3.62M3%
Gain YTD-32.796-96.60034%
P/E RatioN/AN/A-
Revenue18M23.5M77%
Total Cash666K149M0%
Total Debt3.59M258M1%
FUNDAMENTALS RATINGS
ASAPF vs EMITF: Fundamental Ratings
ASAPF
EMITF
OUTLOOK RATING
1..100
8240
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9694
PRICE GROWTH RATING
1..100
8299
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
3575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EMITF's Valuation (14) in the Real Estate Development industry is in the same range as ASAPF (32) in the null industry. This means that EMITF’s stock grew similarly to ASAPF’s over the last 12 months.

EMITF's Profit vs Risk Rating (100) in the Real Estate Development industry is in the same range as ASAPF (100) in the null industry. This means that EMITF’s stock grew similarly to ASAPF’s over the last 12 months.

EMITF's SMR Rating (94) in the Real Estate Development industry is in the same range as ASAPF (96) in the null industry. This means that EMITF’s stock grew similarly to ASAPF’s over the last 12 months.

ASAPF's Price Growth Rating (82) in the null industry is in the same range as EMITF (99) in the Real Estate Development industry. This means that ASAPF’s stock grew similarly to EMITF’s over the last 12 months.

ASAPF's P/E Growth Rating (100) in the null industry is in the same range as EMITF (100) in the Real Estate Development industry. This means that ASAPF’s stock grew similarly to EMITF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASAPFEMITF
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
37%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
42%
Advances
ODDS (%)
Bullish Trend 18 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
ASAPF
Daily Signal:
Gain/Loss:
EMITF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RZLT2.740.32
+13.22%
Rezolute
ENIC4.020.05
+1.26%
Enel Chile SA
NXTT6.880.06
+0.88%
Next Technology Holding Inc
BP34.31-0.27
-0.78%
BP plc
XERS7.21-0.07
-0.96%
Xeris Biopharma Holdings

ASAPF and

Correlation & Price change

A.I.dvisor tells us that ASAPF and EMITF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASAPF and EMITF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASAPF
1D Price
Change %
ASAPF100%
+1.35%
EMITF - ASAPF
24%
Poorly correlated
N/A
PHG - ASAPF
23%
Poorly correlated
+0.37%
EDTXF - ASAPF
22%
Poorly correlated
N/A
NNCSF - ASAPF
21%
Poorly correlated
N/A
MASS - ASAPF
10%
Poorly correlated
+0.74%
More

EMITF and

Correlation & Price change

A.I.dvisor tells us that EMITF and AVHHL have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EMITF and AVHHL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMITF
1D Price
Change %
EMITF100%
N/A
AVHHL - EMITF
26%
Poorly correlated
N/A
KLYG - EMITF
24%
Poorly correlated
N/A
ASAPF - EMITF
24%
Poorly correlated
+1.35%
IQV - EMITF
23%
Poorly correlated
+0.39%
PHG - EMITF
15%
Poorly correlated
+0.37%
More